Table 2. Univariate predictors of the presence of coronary artery collaterals.
Variable | Estimate (x104) | p value |
Angiogenic and angiostatic factors | ||
Angiogenic | ||
CXCL1 | +0.022 | 0.428 |
CXCL3 | +2.895 | 0.056 |
CXCL5 | +0.406 | 0.041 |
CXCL8 | +1.154 | 0.277 |
CXCL12 | +0.579 | 0.169 |
CCL2 | +5.445 | 0.246 |
VEGF* | −0.385 | 0.604 |
bFGF† | +0.346 | 0.100 |
Angiostatic | ||
CXCL9 | +0.014 | 0.722 |
CXCL10 | +0.137 | 0.618 |
CXCL11 | −1.350 | 0.027 |
IFN-γ‡ | −3.858 | 0.013 |
Clinical factors | ||
Hypertension | −2.275 | 0.006 |
Diabetes | −1.017 | 0.053 |
Current tobacco use | −0.418 | 0.431 |
Family history of coronary artery disease | −0.214 | 0.666 |
Hyperlipidemia | +2.087 | 0.032 |
Prior angina pectoris | −0.566 | 0.259 |
Peripheral vascular disease | +0.088 | 0.891 |
Congestive heart failure | −0.522 | 0.586 |
History of cardiac arrhythmias | −0.200 | 0.797 |
Prior myocardial infarction | +0.727 | 0.165 |
Prior stroke | −1.203 | 0.187 |
Prior percutaneous coronary intervention | −0.841 | 0.120 |
Prior coronary artery bypass surgery | −1.734 | 0.006 |
Presence of an occluded artery | +4.302 | <0.0001 |
Number of diseased vessels | −0.003 | 0.990 |
*VEGF = vascular endothelial growth factor, †bFGF = basic fibroblast growth factor, ‡IFN = interferon.